|
|
||||||||
|
|
|||||||||
|
|
Radiopharmaceutical Chemistry: New Chemistry-OtherNew Chemistry-Other Posters |
1 Radiopharmacy, University Hospital Tuebingen, Tuebingen, Germany
1260
Objectives: 6-[18F]Fluoro-L-DOPA is well known as PET biomarker of clinical importance. Commonly, this tracer is synthesized applying electrophilic fluorination with [18F]F2 to yield the c.a. product. Taking into account the advantages of the production of [18F]fluoride, nucleophilic fluorination in the synthesis of [18F]FDOPA is desirable. Here, we report modifications and optimizations on the Lemaire synthesis (1) to improve yield and reliability of the nucleophilic [18F]FDOPA synthesis in an in-house developed automated synthesizer.
Methods: [18F]FDOPA was prepared in 4 steps: a) 18F-fluorination of 4,5-dimethoxy-2-nitrobenzaldehyde (5mg, 1mL DMF, 140°C, K18F/K2.2.2.); purification (C18, ALN cartridges); b) iodination (diiodosilane, r.t.); c) alkylation (CH2Cl2, r.t., 10min, phasetransfer catalyst, CsOH, N-(diphenylmethylene)-glycine tert-butyl ester); d) deprotection (48% HBr, KI, 150°C, 10 min). After neutralization, the product was isolated by RP-HPLC.
Results: [18F]FDOPA was obtained (n = 5) in a yield of 9064 ± 3076 MBq (Irradiation: 120 min; 35 µA). Radiochemical purity was 95 %, specific activity ca. 50 GBq/µmol at EOS and enantiomeric purity ee 95 %. 7 h from EOS radiochemical purity of [18F]FDOPA was > 90 %. Modifications and optimizations of the synthesis in detail: For fluorination, DMF and carbon glass vessels were used instead of DMSO and glass vessels ((2); RCY1 71%±4%); for iodination, diiodosilane was prepared directly before synthesis (RCY2 78%±4%). For hydrolysis HBr and KI were used (instead of HI; (1)); RCY4 76%±8%.
Conclusions: N.c.a. [18F]FDOPA could be synthesized reliably in high yields, in a 4-step process including nucleophilic aromatic substitution with [18F]fluoride. Ref.: (1) Lemaire et al., Eur. J. Org. Chem. 2004, 2899. (2) Al-Labadi et al., Radiochim. Acta 94, 2006, 143.
| ||||||||||||||||||||||||||||||||||||||